Nicholas J. Pritzker is the president and co -founder of Tao Capital PartnersA San Francisco risk capital firm set out in 2013. A prominent American businessman and a member of the influential Pritzker family, Nicholas Pritzker, is widely recognized for his business and leadership as family companies and their own independent efforts. He previously served as President and CEO of the Hyatt Development Corporation and is associated with the substantial business interests of the Pritzker family, including ownership holdings at Hyatt Hotels and Conwood, a leading tobacco tobacco. His academic journey includes studies at Reed College, Lake Forest College and London School of Economics, followed by winning a JD from the University of Chicago.
In Tao Capital Partners, Pritzker oversees a company that strategically focuses on investments in technology, transport, health, education, sustainable foods, alternative energy, agriculture, consumer products, real estate and hospitality. Although he has the role of president, Nicholas Pritzker is not the manager of the firm’s portfolio. Instead, Matthias Bachtel, who is responsible for managing the company’s investment portfolio and making critical financial decisions. Under his leadership, Tao Capital has established a reputation to support innovative and sustainable companies, emphasizing long -term positive impacts along with financial returns.
Tao Capital Partners follows a philosophy of disciplined investments, directing to the sectors that are proposed for growth and transformation. Firm investments include companies in technology and transport industries, as well as those focused on health, educational, sustainable food and clean energy solutions. This diversified approach reflects the company’s commitment not only to achieve financial gains, but also to foster advances in the critical global sectors.
From the fourth quarter of 2024, Tao Capital Partners reported to manage $ 143.28 million in values 13f to ten basic farms. The firm’s commitment to sustainable and shocking investment is aligned with Nicholas Pritzker’s broadest view of taking advantage of capital to promote a positive change. Pritzker’s guidance continues to configure the company’s strategic management, while the Matthias Brachtel portfolio management experience guarantees the optimization of the yields within the chosen sectors. Through a combination of innovative vision and practical financial management, Tao Capital Partners continues to build a diverse portfolio aimed at fostering sustainable growth.
For this article, we have searched for the Tao Capital Archives of 4024 13F to identify the actions of the Multimiler of Nicholas J. Pritzker with the highest potential. We collected actions with a potential in reverse over 2% at the time of writing this article and analyzed why they were highlighted as potential investments. Finally, we classified the stocks based on the ascending order of its potential aside. To help readers with more context, the feeling of the coverage collection around each action was mentioned by means of data of 1,009 coverage funds tracked by Insider Monkey in the fourth quarter of 2024.
Why are we interested in the stocks that cover the funds? The reason is simple: our research has shown that we can overcome the market by imitating the best stock options for the best coverage funds. The strategy of our quarterly bulletin selects 14 stocks of small layers and large layers each quarter and has returned 363.5% since May 2014, exceeding its reference point at 208 percentage points (Check out more details here)).
Twist Bioscience Corporation (TWST) is the best immunology stock to buy now?
A scientist containing a test tube in the laboratory, surrounded by teams used in synthetic biology and discovery of drugs.
Number of coverage fund holders from the fourth quarter: 26
Tao Capital’s Equity Stake: $ 38.52 million
Potential upside down from May 8: 50.11%
Twist Bioscience Corporation (NASDAQ: TWST) is a biotechnology company specializing in the manufacture of synthetic DNA through a semiconductors based process. With headquarters in the south of San Francisco, it twists its high -performance silicon platform to miniaturize DNA synthesis, which offers time and costs to its diverse customer base that covers pharmaceuticals, agriculture and data storage.
For the second quarter of prosecutor 2025, Twist Bioscience Corporation (NASDAQ: TWST) recorded revenue of $ 92.79 million, exceeding expectations of $ 92. billion analysts. Despite this income rate, the company recorded a loss of $ 0.66 per action, and lacking the consensus estimation of a loss of $ 0.56. The negative net margin of 59.76% and the equity performance of 32.69% reflect the ongoing challenges when climbing the business in the middle of the high operating costs. Analysts are currently planning a complete eps of -2.12.
The market capitalization of Twist Bioscience Corporation (NASDAQ: TWST) is $ 2.39 billion, with institutional property reaching 112.29%, which indicates a strong confidence of the great investors despite recent financial difficulties. Company’s semiconduct -based DNA synthesis technology continues to offer unique advantages, which can withstand long -term growth as the demand for synthetic biology solutions increases.
With a price of $ 47.75 and a potential in reverse of 45.67%, Twist Bioscience Corporation (NASDAQ: TWST) is among Nicholas J. Pritzker’s multimillionary actions with great potential. The company’s innovative approach to DNA synthesis and substantial institutional support position positions it as a promising player in the biotechnological space, despite short -term profitability challenges.
Usually twst Ranks 2nd Among the actions of the billionaire of Nicholas J. Pritzker, with great potential on reverse. Although we recognize the potential of TWST as an investment, our conviction lies in the belief that AI actions have a greater promise to obtain higher yields and to do it in a shorter period. There is an AI stock that increased since the beginning of 2025, while the popular AI actions lost around 25%. If you are looking for a stock of Ia more promising than TWST but that sells less than five times, see our report on this Ia stock cheap.
